Healthcare provider profile · identity verified

Susan M Harding, MD

Allopathic & Osteopathic Physicians|Internal Medicine · QUITMAN, GA · NPI 1952396798

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Susan M Harding, MD received $45.25 in general payments during 2025 across 2 reported records.

ABBVIE INC. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

A separate comparison found the same explicitly named product in public Medicare Part D data: Vraylar.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Armour Thyroid by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 106 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Synthroid by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Vraylar by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$45.25

2 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$45.25	100.0%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$45.25	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
VRAYLAR Normalized: vraylar	Drug	ABBVIE INC.	$45.25	2	2025
Source payment records 2025-07-28 · ABBVIE INC. · $21.92 · Open Payments source 2025-11-03 · ABBVIE INC. · $23.33 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
VRAYLAR vraylar	2025	Vraylar	2024	27 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	ARMOUR THYROID open payments reported associated product	CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088	Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row	21	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	106	18
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	32	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	VRAYLAR open payments reported associated product	CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550	Vraylar · 2024 Exact normalized brand match · 1 Part D row	27	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1588	188
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	971	113
Gabapentin	Gabapentin	771	126
Albuterol Sulfate Hfa	Albuterol Sulfate	723	132
Lisinopril	Lisinopril	591	116
Furosemide	Furosemide	558	114
Diclofenac Sodium	Diclofenac Sodium	554	141
Alprazolam	Alprazolam	549	73
Amlodipine Besylate	Amlodipine Besylate	545	94
Potassium Chloride	Potassium Chloride	526	108
Metformin Hcl	Metformin Hcl	505	103
Metoprolol Tartrate	Metoprolol Tartrate	485	85
Tramadol Hcl	Tramadol Hcl	483	69
Atorvastatin Calcium	Atorvastatin Calcium	480	105
Pantoprazole Sodium	Pantoprazole Sodium	452	83
Levothyroxine Sodium	Levothyroxine Sodium	450	84
Omeprazole	Omeprazole	448	97
Oxycodone Hcl	Oxycodone Hcl	438	53
Prednisone	Prednisone	412	172
Meloxicam	Meloxicam	407	84
Diazepam	Diazepam	376	58
Lorazepam	Lorazepam	339	66
Clopidogrel	Clopidogrel Bisulfate	338	62
Tamsulosin Hcl	Tamsulosin Hcl	330	74
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	319	62
Losartan Potassium	Losartan Potassium	317	65
Zolpidem Tartrate	Zolpidem Tartrate	278	38
Amitriptyline Hcl	Amitriptyline Hcl	264	50
Tizanidine Hcl	Tizanidine Hcl	258	53
Baclofen	Baclofen	237	45
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	233	54
Trazodone Hcl	Trazodone Hcl	223	46
Azithromycin	Azithromycin	221	147
Esomeprazole Magnesium	Esomeprazole Magnesium	219	31
Metoprolol Succinate	Metoprolol Succinate	210	40
Simvastatin	Simvastatin	197	37
Famotidine	Famotidine	187	34
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	180	19
Mirtazapine	Mirtazapine	180	38
Quetiapine Fumarate	Quetiapine Fumarate	175	24
Ropinirole Hcl	Ropinirole Hcl	170	30
Carvedilol	Carvedilol	167	31
Escitalopram Oxalate	Escitalopram Oxalate	165	32
Clonidine Hcl	Clonidine Hcl	164	41
Promethazine Hcl	Promethazine Hcl	164	41
Fluticasone Propionate	Fluticasone Propionate	157	47
Montelukast Sodium	Montelukast Sodium	155	28
Jardiance	Empagliflozin	152	29
Buspirone Hcl	Buspirone Hcl	150	34
Pioglitazone Hcl	Pioglitazone Hcl	149	29
Naproxen	Naproxen	148	27
Ibuprofen	Ibuprofen	147	31
Ondansetron Odt	Ondansetron	147	41
Hydrochlorothiazide	Hydrochlorothiazide	146	31
Carisoprodol	Carisoprodol	145	22
Clonazepam	Clonazepam	145	20
Colchicine	Colchicine	135	32
Eliquis	Apixaban	133	24
Pravastatin Sodium	Pravastatin Sodium	133	26
Morphine Sulfate Er	Morphine Sulfate	129	19
Nifedipine Er	Nifedipine	128	31
Cephalexin	Cephalexin	124	71
Sertraline Hcl	Sertraline Hcl	123	25
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	116	19
Ventolin Hfa	Albuterol Sulfate	115	23
Citalopram Hbr	Citalopram Hydrobromide	114	22
Fluconazole	Fluconazole	114	43
Linzess	Linaclotide	106	18
Megestrol Acetate	Megestrol Acetate	104	24
Glipizide	Glipizide	103	25
Levetiracetam	Levetiracetam	103	21
Olanzapine	Olanzapine	103	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	98	16
Xarelto	Rivaroxaban	96	17
Clindamycin Hcl	Clindamycin Hcl	94	34
Digoxin	Digoxin	91	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	90	16
Duloxetine Hcl	Duloxetine Hcl	87	21
Finasteride	Finasteride	86	15
Propranolol Hcl	Propranolol Hcl	84	16
Dicyclomine Hcl	Dicyclomine Hcl	82	17
Aripiprazole	Aripiprazole	80	15
Hydralazine Hcl	Hydralazine Hcl	80	19
Acetaminophen-Codeine	Acetaminophen With Codeine	78	15
Amoxicillin	Amoxicillin	76	38
Fluoxetine Hcl	Fluoxetine Hcl	75	13
Rosuvastatin Calcium	Rosuvastatin Calcium	73	19
Donepezil Hcl	Donepezil Hcl	71	12
Estradiol	Estradiol	71	16
Glimepiride	Glimepiride	66	16
Januvia	Sitagliptin Phosphate	65	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	62	19
Metoclopramide Hcl	Metoclopramide Hcl	60	11
Farxiga	Dapagliflozin Propanediol	59	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	59	40
Ciprofloxacin Hcl	Ciprofloxacin Hcl	58	32
Meclizine Hcl	Meclizine Hcl	58	16
Pregabalin	Pregabalin	58	17
Ozempic	Semaglutide	56	14
Allopurinol	Allopurinol	55	11
Sumatriptan Succinate	Sumatriptan Succinate	55	14
Lamotrigine	Lamotrigine	54	suppressed
Metronidazole	Metronidazole	54	31
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	53	18
Paroxetine Hcl	Paroxetine Hcl	53	12
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	52	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	suppressed
Methocarbamol	Methocarbamol	52	21
Spironolactone	Spironolactone	52	12
Sucralfate	Sucralfate	52	11
Celecoxib	Celecoxib	51	12
Verapamil Er	Verapamil Hcl	48	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	47	14
Morphine Sulfate	Morphine Sulfate	47	suppressed
Ezetimibe	Ezetimibe	46	suppressed
Memantine Hcl	Memantine Hcl	45	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	12
Oxycontin	Oxycodone Hcl	44	suppressed
Gemfibrozil	Gemfibrozil	42	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	12
Metolazone	Metolazone	41	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	17
Nitroglycerin	Nitroglycerin	39	17
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	38	suppressed
Metformin Hcl Er	Metformin Hcl	38	suppressed
Prazosin Hcl	Prazosin Hcl	38	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	37	suppressed
Fentanyl	Fentanyl	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	13
Oxybutynin Chloride Er	Oxybutynin Chloride	37	suppressed
Bumetanide	Bumetanide	36	suppressed
Chlorthalidone	Chlorthalidone	36	suppressed
Mounjaro	Tirzepatide	36	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	suppressed
Benztropine Mesylate	Benztropine Mesylate	34	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	34	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	14
Humulin N	Insulin Nph Human Isophane	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Liothyronine Sodium	Liothyronine Sodium	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Temazepam	Temazepam	30	suppressed
Carbamazepine	Carbamazepine	28	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Penicillin V Potassium	Penicillin V Potassium	27	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Vraylar	Cariprazine Hcl	27	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Indomethacin	Indomethacin	25	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	12
Ziprasidone Hcl	Ziprasidone Hcl	25	suppressed
Atenolol	Atenolol	24	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Solifenacin Succinate	Solifenacin Succinate	24	suppressed
Hysingla Er	Hydrocodone Bitartrate	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Valsartan	Valsartan	22	suppressed
Armour Thyroid	Thyroid,pork	21	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Folic Acid	Folic Acid	20	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	20	suppressed
Nystatin	Nystatin	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Nabumetone	Nabumetone	18	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	17	suppressed
Dilantin	Phenytoin Sodium Extended	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	16	suppressed
Diclofenac Potassium	Diclofenac Potassium	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Levetiracetam Er	Levetiracetam	16	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Risperidone	Risperidone	16	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Haloperidol	Haloperidol	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Chlorzoxazone	Chlorzoxazone	14	suppressed
Cimetidine	Cimetidine	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Guanfacine Hcl	Guanfacine Hcl	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Olanzapine Odt	Olanzapine	13	suppressed
Prasugrel Hcl	Prasugrel Hcl	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	12	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lamictal	Lamotrigine	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$45.25 · 2 records	ABBVIE INC.	VRAYLAR	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Vraylar play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error